Medicine & Life Sciences
Hyperphosphatemia
89%
Medicaid
73%
Chronic Kidney Failure
58%
Economics
51%
Sevelamer
47%
Costs and Cost Analysis
41%
calcium acetate
30%
Health Insurance Reimbursement
16%
Prescriptions
15%
House Calls
14%
General Hospitals
11%
Delivery of Health Care
10%
Dialysis
10%
Comorbidity
9%
Pharmaceutical Services
7%
Pharmaceutical Preparations
7%
Ambulances
7%
Cost of Illness
7%
Facilities and Services Utilization
7%
Hemophilia A
6%
Hypercalcemia
6%
Nursing Homes
6%
African Americans
5%
Health Care Costs
5%
Phosphates
5%
Anemia
5%
Hospital Emergency Service
4%
Inpatients
4%
Outpatients
4%
Hospitalization
4%
Heart Failure
4%
HIV
4%
Retrospective Studies
4%
Hypertension
3%
Demography
3%
Databases
3%
Population
2%
Therapeutics
1%
Social Sciences
end stage renal disease
100%
costs
37%
economics
27%
dialysis center
18%
medication
17%
Healthcare
15%
comorbidity
12%
utilization
12%
economic impact
10%
drug
10%
recipient
8%
driver
8%
emergency room
7%
exclusion criteria
6%
hypertension
6%
medical services
5%
hospitalization
5%
nursing home
5%
racial group
5%
Caucasian
5%
illness
4%
American
3%
inclusion
3%